TR200103067T2 - Renin inhibitörleri - Google Patents

Renin inhibitörleri

Info

Publication number
TR200103067T2
TR200103067T2 TR2001/03067T TR200103067T TR200103067T2 TR 200103067 T2 TR200103067 T2 TR 200103067T2 TR 2001/03067 T TR2001/03067 T TR 2001/03067T TR 200103067 T TR200103067 T TR 200103067T TR 200103067 T2 TR200103067 T2 TR 200103067T2
Authority
TR
Turkey
Prior art keywords
renin inhibitors
glaucoma
restenosis
combinations
compounds
Prior art date
Application number
TR2001/03067T
Other languages
English (en)
Inventor
Breu Volker
Bur Daniel
Peter Maerki Hans
Vieira Eric
Wostl Wolfgang
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR200103067T2 publication Critical patent/TR200103067T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bu bulus formül (I) bilesimleri ve bunlarin farmasötik açidan kabul edilebilir tuzlari ile ilgilidir ki burada R1 ve R2 tarifname ve istemlerde tarif edildikleri gibidirler. Bilesimler, restenoz, glokoma, kardiyak enfarktüs, yüksek basinci ve sonucu organ hasarlari, örn. kalp yetmezligi ve böbrek yetmezligi ile baglantili hastaliklarin tedavisi için kullanislidir.
TR2001/03067T 1999-04-27 2000-04-20 Renin inhibitörleri TR200103067T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108200 1999-04-27

Publications (1)

Publication Number Publication Date
TR200103067T2 true TR200103067T2 (tr) 2002-05-21

Family

ID=8238051

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03067T TR200103067T2 (tr) 1999-04-27 2000-04-20 Renin inhibitörleri

Country Status (22)

Country Link
US (1) US6197959B1 (tr)
EP (1) EP1180103B1 (tr)
JP (1) JP3602449B2 (tr)
KR (1) KR100476916B1 (tr)
CN (1) CN1323079C (tr)
AR (1) AR018717A1 (tr)
AT (1) ATE363478T1 (tr)
AU (1) AU761392B2 (tr)
BR (1) BR0010076A (tr)
CA (1) CA2370244C (tr)
CO (1) CO5170512A1 (tr)
CZ (1) CZ20013737A3 (tr)
DE (1) DE60035039T2 (tr)
ES (1) ES2286021T3 (tr)
HU (1) HUP0200881A3 (tr)
MX (1) MXPA01010855A (tr)
PE (1) PE20010068A1 (tr)
PL (1) PL362903A1 (tr)
SK (1) SK15172001A3 (tr)
TR (1) TR200103067T2 (tr)
WO (1) WO2000064887A1 (tr)
ZA (1) ZA200108739B (tr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
TW200900399A (en) * 2003-10-01 2009-01-01 Speedel Experimenta Ag Organic compounds
AR045950A1 (es) * 2003-10-09 2005-11-16 Speedel Experimenta Ag Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
AU2004293177B2 (en) * 2003-11-26 2008-10-23 Novartis Ag 4-phenylpiperidine derivatives as renin inhibitors
TW200613274A (en) * 2004-07-09 2006-05-01 Speedel Experimenta Ag Organic compounds
CA2580862A1 (en) 2004-10-08 2006-04-20 Novartis Ag Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
GB0428526D0 (en) * 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) * 2005-01-14 2005-02-23 Novartis Ag Organic compounds
AR053836A1 (es) * 2005-03-31 2007-05-23 Speedel Experimenta Ag Piperdinas 3,4,5-sustituidas
EP1707202A1 (de) * 2005-03-31 2006-10-04 Speedel Experimenta AG Organische Verbindungen
ES2352564T3 (es) * 2005-03-31 2011-02-21 Novartis Ag Piperidinas sustituidas.
EP1897879A3 (en) * 2005-03-31 2008-06-11 Speedel Experimenta AG 2,4,5-substituted piperidines as renin inhibitors
TW200833687A (en) * 2005-03-31 2008-08-16 Speedel Experimenta Ag Substituted piperidines
GB0508992D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
JP5306811B2 (ja) * 2005-05-11 2013-10-02 ライフ テクノロジーズ コーポレーション ２本鎖ｄｎａへの高い選択性を有する蛍光化学物質及びそれらの使用
KR100963455B1 (ko) 2005-05-27 2010-06-18 액테리온 파마슈티칼 리미티드 신규한 피페리딘 카르복실산 아미드 유도체
GB0514203D0 (en) * 2005-07-11 2005-08-17 Novartis Ag Organic compounds
US8129411B2 (en) * 2005-12-30 2012-03-06 Novartis Ag Organic compounds
TW200804359A (en) * 2006-01-19 2008-01-16 Speedel Experimenta Ag Substituted 4-phenylpiperidines
EP1908761A1 (en) * 2006-10-04 2008-04-09 Speedel Experimenta AG Organic compounds
BRPI0813900A2 (pt) 2007-06-25 2014-12-30 Novartis Ag Derivados de n5-(2-etoxietil)-n3-(2-piridinil)-3,5-piperidinodicarboxa mida para uso como inibidores de renina
AU2008320806A1 (en) * 2007-11-02 2009-05-07 Novartis Ag 4,4-disubstituted piperidines as renin inhibitors
SG175877A1 (en) * 2009-05-04 2011-12-29 Plexxikon Inc Compounds and methods for inhibition of renin, and indications therefor
WO2013045505A1 (en) 2011-09-28 2013-04-04 Novartis Ag Biomarkers for raas combination therapy
EP2810644A1 (en) 2013-06-06 2014-12-10 Ferrer Internacional, S.A. Oral formulation for the treatment of cardiovascular diseases
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009311A1 (de) * 1995-09-07 1997-03-13 F. Hoffmann-La Roche Ag Neue 4-(oxyalkoxyphenyl)-3-oxy-piperidine zur behandlung von herz- und niereninsuffizienz

Also Published As

Publication number Publication date
JP2002543072A (ja) 2002-12-17
AU761392B2 (en) 2003-06-05
DE60035039T2 (de) 2008-02-07
KR100476916B1 (ko) 2005-03-17
PL362903A1 (en) 2004-11-02
SK15172001A3 (sk) 2002-06-04
CO5170512A1 (es) 2002-06-27
AU4750100A (en) 2000-11-10
HUP0200881A2 (en) 2002-08-28
ES2286021T3 (es) 2007-12-01
EP1180103A1 (en) 2002-02-20
CA2370244C (en) 2007-03-27
DE60035039D1 (de) 2007-07-12
JP3602449B2 (ja) 2004-12-15
CA2370244A1 (en) 2000-11-02
EP1180103B1 (en) 2007-05-30
KR20020005017A (ko) 2002-01-16
CZ20013737A3 (cs) 2002-04-17
US6197959B1 (en) 2001-03-06
ATE363478T1 (de) 2007-06-15
HUP0200881A3 (en) 2003-05-28
CN1323079C (zh) 2007-06-27
MXPA01010855A (es) 2002-05-06
ZA200108739B (en) 2003-01-23
CN1349524A (zh) 2002-05-15
WO2000064887A1 (en) 2000-11-02
PE20010068A1 (es) 2001-01-29
AR018717A1 (es) 2001-11-28
BR0010076A (pt) 2002-01-15

Similar Documents

Publication Publication Date Title
TR200103067T2 (tr) Renin inhibitörleri
NZ514981A (en) Renin inhibitors
NO20083207L (no) Inhibitorer av IAP
MXPA05012466A (es) Derivados de quinolina como inhibidores de fosfodiesterasa.
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
JO2282B1 (en) Oxazole derivatives
CY1111425T1 (el) ΠΑΡΑΓΩΓΑ ΤΗΣ ΠΥΡΙΔΟ[2,1-a]-ΙΣΟΚΙΝΟΛΙΝΗΣ ΩΣ DPP-IV ΑΝΑΣΤΟΛΕΙΣ
TR199801749T2 (tr) 4-Amino-pirimidin-türevleri ve bunlari içeren ilaçlar
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
CU23210A3 (es) NUEVOS COMPUESTOS DE OXABISPIDINE uTIL EN EL TRATAMIENTO DE ARRITMIAS CARDIACAS
BR0011130A (pt) Inibidores de metaloproteases
EA200701504A1 (ru) Индолы, пригодные для лечения воспалений
TR200401735T4 (tr) Giraz önleyicileri ve bunların kullanımları
EA200600223A1 (ru) Замещённый 2-аминотетралины для лечения депрессии
CY1113171T1 (el) Αντιφλεγμονωδεις παραγοντες
TR200201168T2 (tr) CGRP-Antagonistleri-yeni siklopropanlar içeren ilaçlar ve üretim yöntemleri.
NO983992L (no) Serinprotease inhibitorer
SE9904765D0 (sv) Pharmaceutically-useful compounds
NO20061821L (no) Amidometylsubstituerte 1-(karboksyalkyl)-syklopentylkarbonylaminobenzazepin-N-eddiksyrederivater, fremgangsmate og mellomprodukter for deres fremstilling, og medikamenter som inneholder disse forbindelsene
WO2023141432A3 (en) Apol1 inhibitors and methods of use
SE0002739D0 (sv) New use
BR0110255A (pt) Cromenilmetil pirimidinadiaminas como agentes antibacterianos
NO20030500L (no) Dihydroporfyrinderivater og deres anvendelse
DK1226819T3 (da) Inhibitor for 20-HETE-producerende enzym
SE0401539D0 (sv) New compounds